Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010-2020.

Autor: Sørensen AMS; Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, 2400, Copenhagen, NV, Denmark., Wesselhöeft R; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløwsvej 19, 5000, Odense C, Denmark.; Child and Adolescent Mental Health Odense, Mental Health Services in the Region of Southern Denmark, 5000, Odense C, Denmark., Andersen JH; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløwsvej 19, 5000, Odense C, Denmark., Reutfors J; Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden., Cesta CE; Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden., Furu K; Department of Chronic Diseases and Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Hartz I; Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.; Innlandet Hospital Trust, Brumunddal, Norway., Rasmussen L; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløwsvej 19, 5000, Odense C, Denmark. lorasmussen@health.sdu.dk.

Publikováno v: European child & adolescent psychiatry [Eur Child Adolesc Psychiatry] 2023 Oct; Vol. 32 (10), pp. 2049-2056. Date of Electronic Publication: 2022 Jul 13.

KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study.

Autor: Frost MG; University of Copenhagen, Faculty of Health and Medicinal Sciences, Copenhagen, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark. Electronic address: matilde.tejlbo.frost.01@regionh.dk., Jensen KJ; Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Gotfredsen DR; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Sørensen AMS; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Ankarfeldt MZ; Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Louie KS; Amgen Limited, United Kingdom., Sroczynski N; Amgen AB, Denmark., Jakobsen E; Department of Heart, Lung and Vascular Surgery, Odense University Hospital, Denmark., Andersen JL; Department of Oncology Herlev Gentofte Hospital, Denmark., Jimenez-Solem E; University of Copenhagen, Faculty of Health and Medicinal Sciences, Copenhagen, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark; Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Petersen TS; University of Copenhagen, Faculty of Health and Medicinal Sciences, Copenhagen, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Apr; Vol. 178, pp. 172-182. Date of Electronic Publication: 2023 Feb 28.

Ciprofloxacin exposure and adverse pregnancy outcomes: A Danish nationwide cohort study.

Autor: Noergaard M; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark., Gotfredsen DR; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark., Sørensen AMS; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark., Andersen JT; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: BJOG : an international journal of obstetrics and gynaecology [BJOG] 2022 Aug; Vol. 129 (9), pp. 1503-1511. Date of Electronic Publication: 2022 Jan 17.

Exposure to Tramadol During Early Pregnancy and Risk of Spontaneous Abortion or Major Congenital Malformations.

Autor: Sørensen AMS; Department of Clinical Pharmacology, the Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, and the Department of Endocrinology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, the Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, the Institute of Clinical Medicine, University of Copenhagen, Copenhagen, the Department of Rheumatology, Copenhagen University Hospital Glostrup, Glostrup, and the Department of Cardiology, Copenhagen University Hospital Hillerød, Hillerød, Denmark., Noergaard MM, Gotfredsen DR, Kjærbye-Thygesen A, Jimenez-Solem E, Askaa B, Poulsen HE, Horwitz H, Andersen JT

Publikováno v: Obstetrics and gynecology [Obstet Gynecol] 2022 Apr 01; Vol. 139 (4), pp. 545-553. Date of Electronic Publication: 2022 Mar 10.

Drug-related challenges following primary total hip and knee arthroplasty.

Autor: Sørensen AMS; Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Nyeland ME; Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Odgaard A; Department of Orthopaedics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Overgaard S; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Orthopaedic Surgery and Traumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Orthopaedic Research Unit, Department of Orthopaedic Surgery and Traumatology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Jimenez-Solem E; Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology, Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Schelde AB; Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Publikováno v: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 Aug; Vol. 129 (2), pp. 139-147. Date of Electronic Publication: 2021 Jun 09.